ArticleCancer biology & therapy2026

MBD2 suppresses SFRP1 expression and promotes colorectal cancer development by blocking MED19 binding to its methylated promoter.

Xiuji Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.